These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20950165)

  • 21. Adjunct teriparatide therapy with monitoring of bone turnover markers and bone scintigraphy for bisphosphonate-related osteonecrosis of the jaw.
    Ohbayashi Y; Miyake M; Sawai F; Minami Y; Iwasaki A; Matsui Y
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Apr; 115(4):e31-7. PubMed ID: 23246226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteonecrosis of the jaw related to the use of bisphosphonates.
    Van den Wyngaert T; Huizing MT; Vermorken JB
    Curr Opin Oncol; 2007 Jul; 19(4):315-22. PubMed ID: 17545793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Teriparatide therapy for bisphosphonate-related osteonecrosis of the jaw: a case report and narrative review.
    Thumbigere-Math V; Gopalakrishnan R; Michalowicz BS
    Northwest Dent; 2013; 92(1):12-8. PubMed ID: 23516715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral bisphosphonates.
    Zahrowski JJ
    J Am Dent Assoc; 2009 May; 140(5):517-8; author reply 518-9. PubMed ID: 19411514
    [No Abstract]   [Full Text] [Related]  

  • 25. [Diphosphonate therapy and osteonecrosis of the jaw].
    Løkken P; Skoglund LA; Skjelbred P
    Tidsskr Nor Laegeforen; 2007 Aug; 127(15):1945-7. PubMed ID: 17700737
    [No Abstract]   [Full Text] [Related]  

  • 26. Battle over popular bone drug Fosamax bursts into court.
    Moynihan R
    BMJ; 2009 Aug; 339():b3155. PubMed ID: 19661142
    [No Abstract]   [Full Text] [Related]  

  • 27. Bisphosphonate-associated osteonecrosis: experiences in a private practice.
    Marder MZ; Marder RW
    Dent Today; 2008 Oct; 27(10):99-100, 102-3; quiz 103, 98. PubMed ID: 18935863
    [No Abstract]   [Full Text] [Related]  

  • 28. Important aspects concerning alendronate-related osteonecrosis of the jaws: a literature review.
    Iglesias JE; Salum FG; Figueiredo MA; Cherubini K
    Gerodontology; 2015 Sep; 32(3):169-78. PubMed ID: 24256517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteonecrosis of the jaw.
    Drozdzowska B
    Endokrynol Pol; 2011; 62(1):88-92. PubMed ID: 21365586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Inflammation of the jaws during treatment with bisphosphonates].
    Bartl R
    Dtsch Med Wochenschr; 2011 Oct; 136(41):2109-10. PubMed ID: 21971888
    [No Abstract]   [Full Text] [Related]  

  • 31. Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1-34)].
    Harper RP; Fung E
    J Oral Maxillofac Surg; 2007 Mar; 65(3):573-80. PubMed ID: 17307613
    [No Abstract]   [Full Text] [Related]  

  • 32. Administration of teriparatide improves the symptoms of advanced bisphosphonate-related osteonecrosis of the jaw: preliminary findings.
    Kakehashi H; Ando T; Minamizato T; Nakatani Y; Kawasaki T; Ikeda H; Kuroshima S; Kawakami A; Asahina I
    Int J Oral Maxillofac Surg; 2015 Dec; 44(12):1558-64. PubMed ID: 26304604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. US judge rules Merck won't face "punitive damages" in first Fosamax case.
    Moynihan R
    BMJ; 2009 Aug; 339():b3225. PubMed ID: 19661146
    [No Abstract]   [Full Text] [Related]  

  • 34. Relationship between periodontal disease and systemic diseases.
    Alexander RE
    Tex Dent J; 2006 Feb; 123(2):139; author reply 139. PubMed ID: 16579501
    [No Abstract]   [Full Text] [Related]  

  • 35. [Diphosphonates can cause necrosis of the jaw. Patients with malignant skeletal diseases are at risk].
    Jarnbring F; Ulmner M; Blomlöf J; Ljungman P
    Lakartidningen; 2006 May 31-Jun 6; 103(21-22):1741-3. PubMed ID: 16826719
    [No Abstract]   [Full Text] [Related]  

  • 36. Osteonecrosis of the jaw in cancer patients receiving IV bisphosphonates.
    Van Poznak C; Estilo C
    Oncology (Williston Park); 2006 Aug; 20(9):1053-62; discussion 1065-6. PubMed ID: 16986349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical femoral fractures shortly after osteonecrosis of the jaw in a postmenopausal woman taking alendronate for osteoporosis.
    Chiu WY; Lee JJ; Tsai KS
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E723-6. PubMed ID: 23471975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteonecrosis of the jaws and bisphosphonate therapy.
    Ruggiero SL; Drew SJ
    J Dent Res; 2007 Nov; 86(11):1013-21. PubMed ID: 17959890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bisphosphonates-associated osteonecrosis of the jaw: review on reported cases].
    Gering A; Grange L; Villier C; Woeller A; Mallaret M
    Therapie; 2007; 62(1):49-54. PubMed ID: 17374348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bisphosphonate-associated osteonecrosis (BON) of the jaws: a possible treatment?
    Vescovi P; Merigo E; Meleti M; Manfredi M
    J Oral Maxillofac Surg; 2006 Sep; 64(9):1460-2. PubMed ID: 16916694
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.